vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and OCEANEERING INTERNATIONAL INC (OII). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $692.4M, roughly 1.2× OCEANEERING INTERNATIONAL INC). OCEANEERING INTERNATIONAL INC runs the higher net margin — 5.2% vs 0.5%, a 4.7% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 2.7%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs 1.8%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Oceaneering International, Inc. is a subsea engineering and applied technology company based in Houston, Texas, U.S. that provides engineered services and hardware to customers who operate in marine, space, and other environments.
ACHC vs OII — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $692.4M |
| Net Profit | $4.5M | $36.1M |
| Gross Margin | — | — |
| Operating Margin | — | — |
| Net Margin | 0.5% | 5.2% |
| Revenue YoY | 7.5% | 2.7% |
| Net Profit YoY | -50.8% | -79.7% |
| EPS (diluted) | $0.05 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $692.4M | ||
| Q4 25 | $821.5M | $668.6M | ||
| Q3 25 | $851.6M | $742.9M | ||
| Q2 25 | $869.2M | $698.2M | ||
| Q1 25 | $770.5M | $674.5M | ||
| Q4 24 | $774.2M | $713.5M | ||
| Q3 24 | $815.6M | $679.8M | ||
| Q2 24 | $796.0M | $668.8M |
| Q1 26 | $4.5M | $36.1M | ||
| Q4 25 | $-1.2B | $177.7M | ||
| Q3 25 | $36.2M | $71.3M | ||
| Q2 25 | $30.1M | $54.4M | ||
| Q1 25 | $8.4M | $50.4M | ||
| Q4 24 | $32.6M | $56.1M | ||
| Q3 24 | $68.1M | $41.2M | ||
| Q2 24 | $78.5M | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 19.8% | ||
| Q3 25 | — | 20.6% | ||
| Q2 25 | — | 21.3% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | — | 19.9% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | — | 18.0% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 9.8% | ||
| Q3 25 | 4.7% | 11.6% | ||
| Q2 25 | 5.8% | 11.3% | ||
| Q1 25 | 1.7% | 10.9% | ||
| Q4 24 | 4.9% | 10.9% | ||
| Q3 24 | 12.1% | 10.5% | ||
| Q2 24 | 13.4% | 9.0% |
| Q1 26 | 0.5% | 5.2% | ||
| Q4 25 | -143.3% | 26.6% | ||
| Q3 25 | 4.3% | 9.6% | ||
| Q2 25 | 3.5% | 7.8% | ||
| Q1 25 | 1.1% | 7.5% | ||
| Q4 24 | 4.2% | 7.9% | ||
| Q3 24 | 8.4% | 6.1% | ||
| Q2 24 | 9.9% | 5.2% |
| Q1 26 | $0.05 | $0.36 | ||
| Q4 25 | $-12.98 | $1.75 | ||
| Q3 25 | $0.40 | $0.71 | ||
| Q2 25 | $0.33 | $0.54 | ||
| Q1 25 | $0.09 | $0.49 | ||
| Q4 24 | $0.36 | $0.55 | ||
| Q3 24 | $0.74 | $0.40 | ||
| Q2 24 | $0.85 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | — |
| Total DebtLower is stronger | $2.5B | $488.8M |
| Stockholders' EquityBook value | $2.0B | $1.1B |
| Total Assets | $5.5B | $2.6B |
| Debt / EquityLower = less leverage | 1.29× | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $695.9M | ||
| Q3 25 | $118.7M | $7.0M | ||
| Q2 25 | $131.4M | $7.0M | ||
| Q1 25 | $91.2M | $7.0M | ||
| Q4 24 | $76.3M | $504.5M | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
| Q1 26 | $2.5B | $488.8M | ||
| Q4 25 | $2.5B | $487.4M | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | $482.0M | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | $1.1B | ||
| Q4 25 | $1.9B | $1.1B | ||
| Q3 25 | $3.1B | $907.7M | ||
| Q2 25 | $3.1B | $842.1M | ||
| Q1 25 | $3.0B | $773.1M | ||
| Q4 24 | $3.1B | $714.3M | ||
| Q3 24 | $3.0B | $698.0M | ||
| Q2 24 | $3.0B | $651.0M |
| Q1 26 | $5.5B | $2.6B | ||
| Q4 25 | $5.5B | $2.7B | ||
| Q3 25 | $6.4B | $2.5B | ||
| Q2 25 | $6.3B | $2.3B | ||
| Q1 25 | $6.1B | $2.3B | ||
| Q4 24 | $6.0B | $2.3B | ||
| Q3 24 | $5.9B | $2.4B | ||
| Q2 24 | $5.7B | $2.3B |
| Q1 26 | 1.29× | 0.44× | ||
| Q4 25 | 1.28× | 0.46× | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | 0.67× | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | $-76.5M |
| FCF MarginFCF / Revenue | — | -11.1% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $221.1M | ||
| Q3 25 | $73.2M | $101.3M | ||
| Q2 25 | $133.5M | $77.2M | ||
| Q1 25 | $11.5M | $-80.7M | ||
| Q4 24 | $116.7M | $128.4M | ||
| Q3 24 | $163.1M | $91.9M | ||
| Q2 24 | $171.1M | $52.6M |
| Q1 26 | — | $-76.5M | ||
| Q4 25 | $-179.5M | $190.7M | ||
| Q3 25 | $-63.0M | $77.0M | ||
| Q2 25 | $-34.2M | $46.9M | ||
| Q1 25 | $-163.2M | $-106.8M | ||
| Q4 24 | $-86.8M | $94.5M | ||
| Q3 24 | $-27.1M | $67.0M | ||
| Q2 24 | $16.9M | $29.8M |
| Q1 26 | — | -11.1% | ||
| Q4 25 | -21.8% | 28.5% | ||
| Q3 25 | -7.4% | 10.4% | ||
| Q2 25 | -3.9% | 6.7% | ||
| Q1 25 | -21.2% | -15.8% | ||
| Q4 24 | -11.2% | 13.2% | ||
| Q3 24 | -3.3% | 9.9% | ||
| Q2 24 | 2.1% | 4.5% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | 11.3% | 4.6% | ||
| Q3 25 | 16.0% | 3.3% | ||
| Q2 25 | 19.3% | 4.3% | ||
| Q1 25 | 22.7% | 3.9% | ||
| Q4 24 | 26.3% | 4.7% | ||
| Q3 24 | 23.3% | 3.7% | ||
| Q2 24 | 19.4% | 3.4% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.24× | ||
| Q3 25 | 2.02× | 1.42× | ||
| Q2 25 | 4.43× | 1.42× | ||
| Q1 25 | 1.37× | -1.60× | ||
| Q4 24 | 3.58× | 2.29× | ||
| Q3 24 | 2.39× | 2.23× | ||
| Q2 24 | 2.18× | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
OII
| Backlog at end of period | $492.0M | 71% |
| Other | $162.8M | 24% |
| ROV days available | $22.5M | 3% |
| ROV days utilized | $15.1M | 2% |
